Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β

Filippo Minutolo, Rosalba Bellini, Simone Bertini, Isabella Carboni, Annalina Lapucci, Letizia Pistolesi, Giovanni Prota, Simona Rapposelli, Francesca Solati, Tiziano Tuccinardi, Adriano Martinelli, Fabio Stossi, Kathryn E. Carlson, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Marco Macchia

Research output: Contribution to journalArticle

Abstract

Salicylaldoximes possess a hydrogen-bonded pseudocyclic A′ ring in place of the typical phenolic A ring that is characteristic of most estrogen receptor (ER) ligands. Monoaryl-substituted salicylaldoximes were obtained by replacing the phenol moiety (ring A) of the ERβ pharmacophore with the pseudocycle A′ ring, which has previously been shown to behave as a bioequivalent of phenols in nonselective ER ligands. In this series, small substituents (CH3, CN, Cl) were introduced into the central phenyl scaffold. An efficient sequential halogen-selective double cross-coupling reaction was developed for the synthesis of the methyl-substituted ER ligand. The measured ERβ affinity proved to be very sensitive to the effect of central core substituents. The binding affinities of the compounds herein reported were in good agreement with the results of computational docking analysis. The chloro-substituted derivative showed the highest β affinity and selectivity, and it also proved to be an ERβ partial agonist with an EC50 of 11 nM.

Original languageEnglish (US)
Pages (from-to)1344-1351
Number of pages8
JournalJournal of Medicinal Chemistry
Volume51
Issue number5
DOIs
StatePublished - Mar 13 2008

Fingerprint

Estrogen Receptors
Ligands
Halogens
Phenols
Cross Reactions
Phenol
Hydrogen
Estrogens
salicylaldoxime

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Minutolo, F., Bellini, R., Bertini, S., Carboni, I., Lapucci, A., Pistolesi, L., ... Macchia, M. (2008). Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β. Journal of Medicinal Chemistry, 51(5), 1344-1351. https://doi.org/10.1021/jm701396g

Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β. / Minutolo, Filippo; Bellini, Rosalba; Bertini, Simone; Carboni, Isabella; Lapucci, Annalina; Pistolesi, Letizia; Prota, Giovanni; Rapposelli, Simona; Solati, Francesca; Tuccinardi, Tiziano; Martinelli, Adriano; Stossi, Fabio; Carlson, Kathryn E.; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.; Macchia, Marco.

In: Journal of Medicinal Chemistry, Vol. 51, No. 5, 13.03.2008, p. 1344-1351.

Research output: Contribution to journalArticle

Minutolo, F, Bellini, R, Bertini, S, Carboni, I, Lapucci, A, Pistolesi, L, Prota, G, Rapposelli, S, Solati, F, Tuccinardi, T, Martinelli, A, Stossi, F, Carlson, KE, Katzenellenbogen, BS, Katzenellenbogen, JA & Macchia, M 2008, 'Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β', Journal of Medicinal Chemistry, vol. 51, no. 5, pp. 1344-1351. https://doi.org/10.1021/jm701396g
Minutolo F, Bellini R, Bertini S, Carboni I, Lapucci A, Pistolesi L et al. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β. Journal of Medicinal Chemistry. 2008 Mar 13;51(5):1344-1351. https://doi.org/10.1021/jm701396g
Minutolo, Filippo ; Bellini, Rosalba ; Bertini, Simone ; Carboni, Isabella ; Lapucci, Annalina ; Pistolesi, Letizia ; Prota, Giovanni ; Rapposelli, Simona ; Solati, Francesca ; Tuccinardi, Tiziano ; Martinelli, Adriano ; Stossi, Fabio ; Carlson, Kathryn E. ; Katzenellenbogen, Benita S. ; Katzenellenbogen, John A. ; Macchia, Marco. / Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β. In: Journal of Medicinal Chemistry. 2008 ; Vol. 51, No. 5. pp. 1344-1351.
@article{45a766d891bd4964b4ae0b9420f8f6fa,
title = "Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β",
abstract = "Salicylaldoximes possess a hydrogen-bonded pseudocyclic A′ ring in place of the typical phenolic A ring that is characteristic of most estrogen receptor (ER) ligands. Monoaryl-substituted salicylaldoximes were obtained by replacing the phenol moiety (ring A) of the ERβ pharmacophore with the pseudocycle A′ ring, which has previously been shown to behave as a bioequivalent of phenols in nonselective ER ligands. In this series, small substituents (CH3, CN, Cl) were introduced into the central phenyl scaffold. An efficient sequential halogen-selective double cross-coupling reaction was developed for the synthesis of the methyl-substituted ER ligand. The measured ERβ affinity proved to be very sensitive to the effect of central core substituents. The binding affinities of the compounds herein reported were in good agreement with the results of computational docking analysis. The chloro-substituted derivative showed the highest β affinity and selectivity, and it also proved to be an ERβ partial agonist with an EC50 of 11 nM.",
author = "Filippo Minutolo and Rosalba Bellini and Simone Bertini and Isabella Carboni and Annalina Lapucci and Letizia Pistolesi and Giovanni Prota and Simona Rapposelli and Francesca Solati and Tiziano Tuccinardi and Adriano Martinelli and Fabio Stossi and Carlson, {Kathryn E.} and Katzenellenbogen, {Benita S.} and Katzenellenbogen, {John A.} and Marco Macchia",
year = "2008",
month = "3",
day = "13",
doi = "10.1021/jm701396g",
language = "English (US)",
volume = "51",
pages = "1344--1351",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor β

AU - Minutolo, Filippo

AU - Bellini, Rosalba

AU - Bertini, Simone

AU - Carboni, Isabella

AU - Lapucci, Annalina

AU - Pistolesi, Letizia

AU - Prota, Giovanni

AU - Rapposelli, Simona

AU - Solati, Francesca

AU - Tuccinardi, Tiziano

AU - Martinelli, Adriano

AU - Stossi, Fabio

AU - Carlson, Kathryn E.

AU - Katzenellenbogen, Benita S.

AU - Katzenellenbogen, John A.

AU - Macchia, Marco

PY - 2008/3/13

Y1 - 2008/3/13

N2 - Salicylaldoximes possess a hydrogen-bonded pseudocyclic A′ ring in place of the typical phenolic A ring that is characteristic of most estrogen receptor (ER) ligands. Monoaryl-substituted salicylaldoximes were obtained by replacing the phenol moiety (ring A) of the ERβ pharmacophore with the pseudocycle A′ ring, which has previously been shown to behave as a bioequivalent of phenols in nonselective ER ligands. In this series, small substituents (CH3, CN, Cl) were introduced into the central phenyl scaffold. An efficient sequential halogen-selective double cross-coupling reaction was developed for the synthesis of the methyl-substituted ER ligand. The measured ERβ affinity proved to be very sensitive to the effect of central core substituents. The binding affinities of the compounds herein reported were in good agreement with the results of computational docking analysis. The chloro-substituted derivative showed the highest β affinity and selectivity, and it also proved to be an ERβ partial agonist with an EC50 of 11 nM.

AB - Salicylaldoximes possess a hydrogen-bonded pseudocyclic A′ ring in place of the typical phenolic A ring that is characteristic of most estrogen receptor (ER) ligands. Monoaryl-substituted salicylaldoximes were obtained by replacing the phenol moiety (ring A) of the ERβ pharmacophore with the pseudocycle A′ ring, which has previously been shown to behave as a bioequivalent of phenols in nonselective ER ligands. In this series, small substituents (CH3, CN, Cl) were introduced into the central phenyl scaffold. An efficient sequential halogen-selective double cross-coupling reaction was developed for the synthesis of the methyl-substituted ER ligand. The measured ERβ affinity proved to be very sensitive to the effect of central core substituents. The binding affinities of the compounds herein reported were in good agreement with the results of computational docking analysis. The chloro-substituted derivative showed the highest β affinity and selectivity, and it also proved to be an ERβ partial agonist with an EC50 of 11 nM.

UR - http://www.scopus.com/inward/record.url?scp=41749116413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749116413&partnerID=8YFLogxK

U2 - 10.1021/jm701396g

DO - 10.1021/jm701396g

M3 - Article

C2 - 18269232

AN - SCOPUS:41749116413

VL - 51

SP - 1344

EP - 1351

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 5

ER -